The global cancer immunotherapy market is primarily driven by the rising prevalence of cancer worldwide, leading to a growing demand…
Zürich (www.aktiencheck.de) - Merck & Co-Aktienanalyse von der UBS:
Aktuelle Bewertung
Der UBS-Analyst, Trung Huynh, hat das Kursziel für Merck & Co…
…
Wien (www.aktiencheck.de) - Merck-Aktienanalyse der Raiffeisen Bank International AG:
Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), rät in einer…
Merck: Darmstadt, Deutschland (ots/PRNewswire) - - Sichere cyber-physische Plattform M-Trust™ für vertrauenswürdigen digitalen Datenaustausch ermöglicht Erstellung digitaler Zwillinge zur Erhöhung…
…
Viking Therapeutics (NASDAQ: VKTX) didnt exactly capture investors hearts in the final month of 2024. The biotech companys share price…
No one knows for sure what the new year will hold for the market. However, some stocks chances for success…
Its been an excellent year for Viking Therapeutics (NASDAQ: VKTX), a mid-cap biotech company. Thanks to impressive mid-stage clinical results,…
Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock…
Investing in dividend stocks can be an excellent way to boost your income each year. But the challenge can be…
The healthcare sector has long been a sanctuary for income investors seeking stability and growth. Within this realm, Bristol-Myers Squibb…
Stocks splits have been a huge market theme in 2024, with big names across industries, from technology giant Nvidia to…
What do many kids like most about the coming of a new year? The fireworks. Investors dont mind seeing some…
Some favorites of the Dow Jones Industrial Average, including Nvidia and Merck, could surge next year.…
There is plenty to like about Merck (NYSE: MRK). It is one of the largest pharmaceutical companies and the owner…
Mit strategischen Zukäufen treibt die deutsche Merck ihr geplantes Wachstum zielgerichtet voran. Die Anleger zeigen sich zuletzt aber skeptisch -…
Watch out, Eli Lilly and Novo Nordisk. Merck (NYSE: MRK) is hungrily looking to take a bite out of the…
Successfully navigating the stock market requires patience and a long-term perspective. The key is sticking to a consistent plan and…
The weight-loss biotech Viking Therapeutics (NASDAQ: VKTX) saw its stock get absolutely slammed on Dec. 18, falling 18% as a…
Die Merck KGaA verzeichnet in den letzten Handelstagen des Jahres 2024 eine deutliche Abwärtsbewegung an der Frankfurter Börse. Der Pharma-…
News of a fresh licensing deal by a well-capitalized rival sent Viking Therapeutics (NASDAQ: VKTX) stock into something of a…
BMO cuts rating on Merck and Biogen, on lack of near term catalyst…
It hasnt been the best quarter for Merck & Co., Inc. ( NYSE:MRK ) shareholders, since the share price has…
Collecting dividend income on a recurring basis can help strengthen your financial position and be a way for you to…
Modernas (NASDAQ: MRNA) wild success in the COVID-19 vaccine market has worn off. The companys revenue, earnings, and stock price…
Summit Therapeutics (NASDAQ: SMMT) has risen in prominence in the past two years thanks to a promising pipeline candidate, ivonescimab,…
A five-bagger in only five years? Any investor would love to buy such a stock. Fortunes can be made quickly…
Merck posts positive data from two phase III studies evaluating a two-drug, single-tablet regimen of doravirine/islatravir in adults with HIV-1…
Mercks HIV treatment meets main goal of two late-stage studies…
Merck gets exclusive global rights to develop, manufacture and commercialize GLP-1 receptor agonist, HS-10535, from Hansoh Pharma.…
Am US-Aktienmarkt zeichnen sich am Mittwoch zum Handelsstart moderate Gewinne ab. Im Fokus steht die Leitzinsentscheidung zwei Stunden vor Börsenschluss…
Der Pharmakonzern hat eine Lizenzvereinbarung mit dem chinesischem Biotech-Unternehmen Hansoh geschlossen. Merck darf künftig die Abnehmpille der Chinesen vermarkten und…
Merck will pay Hansoh $112 million upfront for rights to the drug, with the potential for an additional $1.9 billion…
Kulmbach (www.aktiencheck.de) - Merck & Co-Aktienanalyse von "Der Aktionär":
Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Merck &…
Merck & Co Inc (NYSE:MRK, ETR:6MK) has sought a potential weight loss drug candidate through a deal worth up to…
Investing in biotech stocks usually isnt for the faint of heart. These stocks tend to be highly volatile because of…
Vor der wichtigen Notenbanksitzung heute Abend halten sich die deutschen Anleger zurück. Der DAX hat den Handel am Dienstag bei…
Vor der wichtigen Notenbanksitzung heute Abend halten sich die deutschen Anleger zurück. Der DAX hat den Handel am Dienstag bei…
The FDA accepts MRKs BLA for clesrovimab, its monoclonal antibody, to protect infants from RSV disease. A decision from the…
DARMSTADT (dpa-AFX) - Der Darmstädter Pharma- und Technologiekonzern Merck stärkt sein Geschäft mit einer weiteren Übernahme. Der Dax -Konzern…
DARMSTADT (dpa-AFX) - Der Darmstädter Pharma- und Technologiekonzern Merck stärkt sein Geschäft mit einer weiteren Übernahme. Der DAX-Konzern kauft das…
…
…
…
Its been a good year for the stock market as a whole and a tremendous year for a couple of…
Normally, you might expect to achieve significant gains from stocks if you invest in them for years, perhaps decades. But…
…
Its been a banner year for the stock market. However, not every stock has been a winner as some sectors…
It hasnt been a great year for Iovance Biotherapeutics (NASDAQ: IOVA), an innovative mid-cap biotech company. The drugmakers shares have…